Trexquant Investment LP - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$70,861
-85.1%
20,421
-80.1%
0.00%
-83.3%
Q2 2023$476,848
-43.6%
102,548
-43.9%
0.01%
-47.8%
Q1 2023$844,832
-32.2%
182,864
+18.6%
0.02%
-34.3%
Q4 2022$1,245,984
+288.2%
154,206
+166.5%
0.04%
+218.2%
Q3 2022$321,000
+53.6%
57,869
+312.1%
0.01%
-15.4%
Q4 2021$209,000
-17.4%
14,041
-56.9%
0.01%
-27.8%
Q2 2020$253,000
+125.9%
32,601
+219.1%
0.02%
+157.1%
Q4 2019$112,00010,2150.01%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders